According to new data from the World Health Organization (WHO), years of progress in combating Tuberculosis (TB) are now at risk as governments and donors pull back crucial funding, leaving millions vulnerable to preventable deaths.

The WHO’s latest report, released ahead of World Tuberculosis Day 2025, paints a sobering picture: while infection rates had been steadily declining for over a decade, progress has now stalled or reversed in several high-burden regions, including parts of Africa, Southeast Asia, and Eastern Europe.

Funding Gaps Undermine Decades of Progress

In 2018, world leaders pledged to “end TB by 2030.” Yet, as of this year, only half of the financial commitments have been fulfilled.
The WHO estimates that over $5.8 billion in annual funding is still missing from the global TB response, money needed to sustain testing, treatment, and vaccine development.

“Without immediate financial reinvestment, millions of lives are at risk,” warned Dr. Tereza Kasaeva, Director of the WHO Global TB Programme. “We are at a tipping point, if we lose momentum now, we risk undoing 20 years of progress.”

The Human Cost of Inaction

Each year, Tuberculosis (TB) still infects around 10 million people and kills 1.3 million, making it one of the top infectious killers worldwide  surpassing even HIV/AIDS in mortality in some regions.

The situation worsened during the COVID-19 pandemic, when health systems shifted resources away from Tuberculosis (TB) diagnosis and treatment.
Now, as economic pressures mount and international aid declines, many low-income nations are struggling to restore pre-pandemic capacity.

“We see patients walking hours to clinics only to find no medicine available,” said Dr. Samuel Moyo, a public health expert in Zimbabwe. “It’s heartbreaking. TB doesn’t wait for budgets.”

Innovation Stalled, But Hope Persists

Funding shortfalls have also delayed promising scientific breakthroughs.
 Clinical trials for next-generation Tuberculosis - TB - vaccines and shorter treatment regimens are progressing slower than expected due to limited investment. Meanwhile, drug-resistant TB strains are spreading faster, particularly in overcrowded urban centers and refugee zones.

Yet, not all hope is lost. Organizations like the Global Fund, Bill & Melinda Gates Foundation, and Stop TB Partnership continue to support key research and supply chain programs.

 Digital tools and AI-based diagnostic systems are being deployed in select pilot countries, a glimpse of what a modern, data-driven TB response could look like.

 A Call for Global Solidarity

Experts warn that Tuberculosis - TB- is not a localized issue; it’s a global one.
 With increased migration, urbanization, and weakened healthcare systems, infectious diseases can cross borders rapidly.
 That’s why the WHO is calling for a renewed international commitment ahead of the 2026 UN High-Level Meeting on Global Health.

“Tuberculosis thrives where inequality exists,” said Dr. Kasaeva. “Ending TB isn’t just about medicine, it’s about justice, investment, and political will.”

The fight against TB stands at a crossroads. The world has the tools to end the disease — but not yet the resources or urgency to match.
 Unless funding and focus are restored, experts warn that TB could re-emerge as the defining global health crisis of the next decade.